Adjuvant Chemotherapy for Non-Small Cell Lung Cancer

Phase-Based Progress Estimates
Allegheny Health Network Research Institute, Pittsburgh, PANon-Small Cell Lung CancerAdjuvant Chemotherapy - Drug
All Sexes
What conditions do you have?

Study Summary

This trial is testing whether post-operative chemotherapy is better than radiographic surveillance for stage I or stage IIA non-small cell lung cancer patients.

Eligible Conditions
  • Non-Small Cell Lung Cancer

Treatment Effectiveness

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 5 years

5 years
Disease-Free Survival
Overall Survival

Trial Safety

Trial Design

2 Treatment Groups

Adjuvant Chemotherapy
1 of 2
1 of 2

Active Control

1050 Total Participants · 2 Treatment Groups

Primary Treatment: Adjuvant Chemotherapy · No Placebo Group · N/A

Adjuvant ChemotherapyActiveComparator Group · 2 Interventions: Adjuvant Chemotherapy, 14-Gene Prognostic Assay · Intervention Types: Drug, Other
ObservationActiveComparator Group · 2 Interventions: Radiographic surveillance, 14-Gene Prognostic Assay · Intervention Types: Other, Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 5 years

Who is running the clinical trial?

Razor GenomicsLead Sponsor
Encore ClinicalOTHER
David R Spigel, MDPrincipal InvestigatorSarah Cannon, The Cancer Institute of HCA Healthcare
8 Previous Clinical Trials
468 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 9 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
If you didn't have lung cancer, you would be expected to live at least 5 more years.

Frequently Asked Questions

Are there various venues where this experiment is being conducted in the state?

"Allegheny Health Network Research Institute in Pittsburgh, Pennsylvania, Mercy Oncology Research St. Louis in Saint Louis, Missouri and Highlands Oncology Group in Springdale, Arkansas are all participating sites for this research trial; 20 other medical centres have been recruited as well." - Anonymous Online Contributor

Unverified Answer

Is there any remaining availability to join this medical experiment?

"This experiment, first introduced on the 11th of September 2020 and updated most recently on the 1st November 2022, is presently seeking new participants according to data available on" - Anonymous Online Contributor

Unverified Answer

What is the current sample size of individuals participating in this clinical trial?

"The sponsor, Razor Genomics, has identified a need for 1050 participants that meet the study's eligibility requirements. The trial will operate out of Allegheny Health Network Research Institute in Pittsburgh and Mercy Oncology Research St. Louis within Missouri." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.